Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - SHORT-TERM INVESTMENTS
Short-term Investments TRVI - Trevi Therapeutics, Inc.
50.6 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR